Clinical Trial Update: Effect of Kava on Anxiety and Stress in Cancer Survivors [EARLY_Phase 1]

View source ↗

Summary

Status update of an early-phase 1 trial evaluating kava for anxiety and stress in cancer survivors; the study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Cancer
• Depressive Disorder
• Insomnia

Drugs mentioned

• Kava (Piper methysticum)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Kava, Anxiety | EARLY_Phase 1 | Status: SUSPENDED